BIOMAT Database Logo BIOMAT Database Logo

2-Halogenoethylamines as potential folic acid antagonists. I. Synthesis and biological activity of ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)-propyl]-p-aminobenzoate. 1965

A M Triggle, and D J Triggle

UI MeSH Term Description Entries
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D062365 Aminobenzoates Derivatives of BENZOIC ACID that contain one or more amino groups attached to the benzene ring structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobenzoate structure. Aminobenzoic Acids,Acids, Aminobenzoic

Related Publications

A M Triggle, and D J Triggle
ANALOGS OF TETRAHYDROFOLIC ACID. VII. SYNTHESIS OF N-(1-(2-AMINO- 4-HYDROXY-6-METHYL-5-PYRIMIDYL)-3-PROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID, AN INHIBITOR OF FOLIC REDUCTASE.
September 1963, Journal of pharmaceutical sciences,
A M Triggle, and D J Triggle
ANALOGS OF TETRAHYDROFOLIC ACID. 8. SYNTHESIS OF N-(1-(2-AMINO-4-MERCAPTO-6-METHYL-5-PYRIMIDYL)-3-PROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID, A MERCAPTO ANALOG.
November 1963, Journal of medicinal chemistry,
A M Triggle, and D J Triggle
ANALOGS OF TETRAHYDROFOLIC ACID. IX. SYNTHESIS OF N-(1-(2-AMINO-4-HYDROXY-6-PHENYL-5-PYRIMIDYL)-3-PROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID, A "NONCLASSICAL" INHIBITOR OF SOME FOLIC COFACTOR AREA ENZYMES.
November 1963, Journal of medicinal chemistry,
A M Triggle, and D J Triggle
ANALOGS OF TETRAHYDROFOLIC ACID. XI. SYNTHESIS AND ENZYMIC EVALUATION OF P-((N-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYL)CARBAMOYLMETHYL)AMINO)BENZOYL-L-GLUTAMIC ACID.
September 1964, Journal of pharmaceutical sciences,
A M Triggle, and D J Triggle
Ethyl 6-amino-5-cyano-2-methyl-4-propyl-4H-pyran-3-carboxyl-ate.
October 2009, Acta crystallographica. Section E, Structure reports online,
A M Triggle, and D J Triggle
[Synthesis and biological activities of 1-alkyl-1-benzyl-4-(3-chloro-2-hydroxy)propyl piperazinium halides].
January 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
A M Triggle, and D J Triggle
Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
February 1988, Journal of medicinal chemistry,
A M Triggle, and D J Triggle
Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes.
March 2007, Archiv der Pharmazie,
A M Triggle, and D J Triggle
Synthesis and structure-activity relationships of 1-arylmethyl-3-(1-methyl-2-amino)ethyl-5-aryl-6-methyluracils as antagonists of the human GnRH Receptor.
October 2003, Bioorganic & medicinal chemistry letters,
A M Triggle, and D J Triggle
(Z)-Ethyl 3-[bis-(4-chloro-3-ethyl-1-methyl-1H-pyrazol-5-yl-carbon-yl)amino]-3-(4-chloro-phen-yl)-2-cyano-propanoate.
March 2009, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!